Mallinckrodt begins enrolment in Phase IIa study for liver cirrhosis
The Phase IIa trial will enrol patients with hepatic cirrhosis and a history of at least two or more documented HE episodes. Credit: BruceBlaus.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more